Abstract
Interleukin-25 (IL-25) plays a key role in the initiation and expansion of T helper (Th) 2 cell-mediated immune responses, thereby contributing to allergic diseases and host defense against helminthic parasites. More recent studies have however shown that IL-25 can also control the function of non-T cells, such as antigen presenting cells and endothelial cells, and reduces Th1/Th17-mediated pathologies. These new and exciting observations reveal a broader role for IL-25 than previously anticipated, and delineate various scenarios where therapeutic interventions around IL-25 activity can be imagined.
Keywords: IL-25, IBD, multiple sclerosis, diabetes, allergic diseases, Th cells, noxious agents, inflammatory bowel disease, TNF-, immunoglobulin E, inflammation, monoclonal antibodies, lymphoid tissue, immunity, nuocyte, Nippostrongylus brasiliensis, endotoxemia, preceding the development of overt disease, reduces the degree of CD4- and CD8-positive per-islet infi, RNA transcripts, atopic dermatitis, Crohn's disease, celiac disease, gluten-sensitive enteropathy
Current Molecular Medicine
Title: The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies
Volume: 11 Issue: 1
Author(s): R. Caruso, C. Stolfi, D. De Nitto, F. Pallone and G. Monteleone
Affiliation:
Keywords: IL-25, IBD, multiple sclerosis, diabetes, allergic diseases, Th cells, noxious agents, inflammatory bowel disease, TNF-, immunoglobulin E, inflammation, monoclonal antibodies, lymphoid tissue, immunity, nuocyte, Nippostrongylus brasiliensis, endotoxemia, preceding the development of overt disease, reduces the degree of CD4- and CD8-positive per-islet infi, RNA transcripts, atopic dermatitis, Crohn's disease, celiac disease, gluten-sensitive enteropathy
Abstract: Interleukin-25 (IL-25) plays a key role in the initiation and expansion of T helper (Th) 2 cell-mediated immune responses, thereby contributing to allergic diseases and host defense against helminthic parasites. More recent studies have however shown that IL-25 can also control the function of non-T cells, such as antigen presenting cells and endothelial cells, and reduces Th1/Th17-mediated pathologies. These new and exciting observations reveal a broader role for IL-25 than previously anticipated, and delineate various scenarios where therapeutic interventions around IL-25 activity can be imagined.
Export Options
About this article
Cite this article as:
Caruso R., Stolfi C., De Nitto D., Pallone F. and Monteleone G., The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies, Current Molecular Medicine 2011; 11 (1) . https://dx.doi.org/10.2174/156652411794474365
DOI https://dx.doi.org/10.2174/156652411794474365 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Programmed Symptoms: Disparate Effects United by Purpose
Current Rheumatology Reviews Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery Medicinal Chemistry Insights into Novel HDAC Inhibitors: An Updated Patent Review (2012-2016)
Recent Patents on Anti-Cancer Drug Discovery Mechanisms of Control of Neuron Survival by the Endocannabinoid System
Current Pharmaceutical Design Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Current Medicinal Chemistry The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy
Current Medicinal Chemistry Role of Interleukin-21 in Inflammation and Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Mitochondria-Targeted Drugs
Current Molecular Pharmacology Midkine in Inflammatory and Toxic Conditions
Current Drug Delivery Association of Viruses in the Development of Cardiovascular Diseases
Current Pharmaceutical Design IL-2 Receptor Targeted Immunomodulatory Biologics: The Past, Present, and Future
Current Immunology Reviews (Discontinued) A Genopedia of Lupus Genes - Lessons from Gene Knockouts
Current Rheumatology Reviews Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology
Current Pharmaceutical Design Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives
Current Medicinal Chemistry Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis
Current Medicinal Chemistry Effect of Inhibitors of Nitric Oxide in Animal Models and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Salen Mn Complexes are Superoxide Dismutase/Catalase Mimetics that Protect the Mitochondria
Current Inorganic Chemistry (Discontinued) Stem Cells as a Potential Therapeutic Option for Treating Neurodegenerative Diseases
Current Stem Cell Research & Therapy